argenx is a clinical-stage biotechnology company developing differentiated therapies for the treatment of severe autoimmune diseases and cancer. Co. is developing its main product candidate, efgartigimod, for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris and chronic demyelinating polyneuropathy, all of which are severe autoimmune diseases associated with high levels of circulating pathogenic immunoglobulin G antibodies for which there are few biologic treatments and a severe unmet medical need exists. Co. is also developing cusatuzumab in hematological cancer indications, acute myeloid leukemia, as well as high-risk myelodysplastic syndrome. We show 1 historical shares outstanding datapoints in our ARGX shares outstanding history coverage, used to compute ARGX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ARGX market cap history over the course of time is important for investors
interested in comparing ARGX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ARGX versus a peer is one thing; comparing
ARGX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ARGX can fluctuate over the course of history.
With this page we aim to empower investors researching ARGX by allowing them to research the ARGX market cap history. |
Free ARGX Email Alerts:
Video: The Importance of Market Cap
